Welcome to Innate Pharma

About Innate Pharma

Innate Pharma S.A. is a commercial stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.

See company profile

Headlines

Innate Pharma reports first half 2019 financial results and business update

Friday, September 13, 2019. Webcast and conference call will be held Friday, September 13 at 2:00pm (CEST)

See the Press Release and access to the webinar

ICML 2019: "TELLOMAK” clinical trial design and rationale and KOL webcast

A KOL webcast and conference call was held on Thursday, June 20, 2019

See the Press Release and access to the replay

Innate Pharma announces publication of IPH4102 Phase I clinical trial results for CTCL in the Lancet Oncology

Publication in The Lancet Oncology of the results from the completed Phase I dose-escalation and expansion clinical trial of IPH4102 in advanced CTCL patients.

See the Press Release and access to the publication